Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

5.66
Delayed Data
As of Mar 24
 +0.1262 / +2.28%
Today’s Change
4.76
Today|||52-Week Range
8.24
-4.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues6.0M7.6M10.2M9.5M
 
 
 
 
 
Cost of Goods Sold2.5M2.7M3.5M4.1M
 
 
 
 
 
Depreciation And Amortization417.2K446.0K525.9K--
 
 
 
 
 
Operating ExpensesGross Income3.1M4.4M6.3M5.4M
 
 
 
 
 
General Expenses3.1M4.7M4.1M4.5M
 
 
 
 
 
Research And Development1.2M2.2M1.2M1.2M
 
 
 
 
 
Total Operating Expenses6.0M7.8M8.1M8.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.6K-206.4K2.1M890.0K
 
 
 
 
 
Interest Expense On Debt69.6K60.7K83.6K--
 
 
 
 
Other Expenses281.9K-3.9K5.6K-132.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income205.3K-255.5K2.1M758.0K
 
 
 
 
 
Income Taxes-87.9K-88.3K-850.3K-250.0K
 
 
 
 
 
Net Income117.4K-167.2K1.2M508.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M3.0M3.0M4.2M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M3.0M3.2M4.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04-$0.06$0.38$0.12
 
 
 
 
 
EPS Diluted$0.04-$0.06$0.38$0.12